Clearside Biomedical’s (CLSD) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of Clearside Biomedical (NASDAQ:CLSD – Free Report) in a report published on Thursday morning,Benzinga reports. HC Wainwright currently has a $6.00 target price on the stock. Other analysts also recently issued research reports about the company. Needham & Company LLC reiterated a “buy” rating and set a […]
HC Wainwright reissued their buy rating on shares of Clearside Biomedical (NASDAQ:CLSD – Free Report) in a report published on Thursday morning,Benzinga reports. HC Wainwright currently has a $6.00 target price on the stock. Other analysts also recently issued research reports about the company. Needham & Company LLC reiterated a “buy” rating and set a […]
